###begin article-title 0
###xml 3 5 3 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 72 75 <span type="species:ncbi:10116">rat</span>
P2Y1 receptor switches to neurons from glia in juvenile versus neonatal rat cerebellar cortex
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
In the CNS, several P2 receptors for extracellular nucleotides are identified on neurons and glial cells to participate to neuron-neuron, glia-glia and glia-neuron communication.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 83 85 83 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 320 322 320 322 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 490 492 490 492 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 704 706 701 703 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 934 936 931 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1172 1174 1169 1171 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 97 100 <span type="species:ncbi:10116">rat</span>
In this work, we describe the cellular and subcellular presence of metabotropic P2Y1 receptor in rat cerebellum at two distinct developmental ages, by means of immunofluorescence-confocal and electron microscopy as well as western blotting and direct membrane separation techniques. At postnatal day 21, we find that P2Y1 receptor in addition to Purkinje neurons, is abundant on neuronal specializations identified as noradrenergic by anatomical, morphological and biochemical features. P2Y1 receptor immunoreactivity colocalizes with dopamine beta-hydroxylase, tyrosine hydroxylase, neurofilament light chain, synaptophysin and flotillin, but not with glial fibrillary acidic protein for astrocytes. P2Y1 receptor is found enriched in membrane microdomains such as lipid rafts, in cerebellar synaptic vesicles, and is moreover visualized on synaptic varicosities by electron microscopy analysis. When examined at postnatal day 7, P2Y1 receptor immunoreactivity is instead predominantly expressed only on Bergmann and astroglial cells, as shown by colocalization with glial fibrillary acidic protein rather then neuronal markers. At this age, we moreover identify that P2Y1 receptor-positive Bergmann fibers wrap up doublecortin-positive granule cells stretching along them, while migrating through the cerebellar layers.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 174 176 174 176 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Membrane components including purinergic receptors are already known to mediate cellular contact and aggregation in platelets. Our results suggesting a potential role for P2Y1 protein in cell junction/communication and development, are totally innovative for the CNS.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 224 225 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 462 463 462 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 510 513 510 513 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1&#8211;7</sub>
###xml 516 517 516 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 559 578 559 578 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1,2,4,6,11,12,13,14</sub>
###xml 581 582 581 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 908 909 908 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 910 912 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 982 984 982 984 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1020 1022 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1039 1041 1039 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1078 1080 1078 1080 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1256 1258 1256 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1274 1276 1274 1276 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1404 1406 1404 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1429 1431 1429 1431 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1604 1606 1604 1606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1013 1018 <span type="species:ncbi:9606">human</span>
###xml 1028 1031 <span type="species:ncbi:10116">rat</span>
###xml 1047 1052 <span type="species:ncbi:9606">human</span>
###xml 1394 1402 <span type="species:ncbi:9606">patients</span>
###xml 1443 1446 <span type="species:ncbi:10116">rat</span>
Extracellular nucleotides partake to excitatory neurotransmission and neuromodulation in the CNS and are capable of intervening in a broad array of physiopathological functions acting on different P2 purinergic receptors [1-3]. Because of their heterogeneous faculty of responding to several diverse nucleotides, interest is growing on discovering the exact localization of the various P2 receptor subunits in selected organs, tissues and cellular phenotypes [4,5]. To date, seven different ionotropic P2X (P2X1-7) [6] and eight distinct metabotropic P2Y (P2Y1,2,4,6,11,12,13,14) [7] receptors were cloned from mammalian species. In contrast to P2X ion channels, P2Y proteins hold the general feature of G protein-coupled receptors with seven hydrophobic transmembrane domains. Since activation of P2Y subtypes leads to second messenger cascades, their response is slower than that mediated by P2X subunits [8-10]. Among P2Y receptors, an elevated expression particularly of the P2Y1 subtype was detected in both human [11] and rat brain [12]. In human tissue, expression of P2Y1 protein is reported exclusively on neuronal cells in cerebral and cerebellar cortex, in hippocampus, caudate-putamen nuclei, globus pallidus, subthalamic nucleus and midbrain [11]. Moreover, P2Y1 protein appears associated to neurofibrillary tangles and neuritic plaques in postmortem brain of Alzheimer's disease patients [13]. On the contrary, P2Y1 receptor in rat is detected not only on grey matter, particularly cerebellar, cortical and hippocampal neurons, but also on white matter of corpus callosum and optic nerve [12].
###end p 9
###begin p 10
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 210 212 210 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 318 320 318 320 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 504 506 504 506 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 662 664 662 664 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 576 579 <span type="species:ncbi:10116">rat</span>
Many studies have already highlighted a general role for purinergic signaling in brain development [14] and in neuron and/or glia function and communication [15-17]. For instance, activation particularly of P2Y1 receptor is suggested to regulate oligodendrocyte progenitor functions [18], whereas reduced levels of P2Y1 protein apparently affect proliferation and migration, but not differentiation of neural progenitor cells during early CNS development [19]. With the present work, we further study P2Y1 receptor and compare protein distribution in juvenile versus neonatal rat cerebellum. We show that during postnatal growth, the phenotypic appearance of P2Y1 protein undergoes a drastic switch from glial to neuronal localization, therefore suggesting this receptor as a novel marker of cerebellar development.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 3 5 3 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 109 112 <span type="species:ncbi:10116">rat</span>
P2Y1 receptor is present on tyrosine hydroxylase- and dopamine beta-hydroxylase-positive neurons in juvenile rat cerebellum
###end title 12
###begin p 13
###xml 93 95 93 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 212 214 212 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 317 318 317 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 451 453 451 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 648 649 648 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 656 657 656 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 698 700 698 700 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 932 933 932 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1004 1006 1004 1006 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1161 1163 1161 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1259 1261 1259 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1350 1351 1344 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1395 1397 1389 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1446 1448 1440 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1466 1467 1457 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1476 1478 1467 1469 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1513 1515 1504 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 1629 1631 1620 1622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1647 1649 1638 1640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 1686 1688 1677 1679 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1799 1801 1787 1789 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1814 1816 1802 1804 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 2166 2168 2154 2156 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 2200 2202 2185 2187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 2238 2240 2223 2225 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 2429 2431 2413 2415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 2453 2455 2437 2439 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 2470 2472 2454 2456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 2554 2556 2538 2540 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 2687 2688 2671 2672 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 2935 2937 2919 2921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 2988 2989 2972 2973 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 3068 3069 3052 3053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 3109 3110 3093 3094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 3216 3218 3200 3202 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 142 145 <span type="species:ncbi:10116">rat</span>
We describe in this work the topographic cellular and subcellular in vivo distribution of P2Y1 receptor protein in the cerebellum of juvenile rat at postnatal day 21 (P21). We show by confocal microscopy that P2Y1 protein immunoreactivity is uniformly distributed throughout specific zones of cerebellar cortex (Fig. 1). Confirming what was previously depicted by immunohistochemical observations [12], our immunofluorescence studies indicate that P2Y1 receptor is limited to Purkinje cell (pc) bodies and ramifications, to neuropil of molecular layer (ml), and to axons of white matter irradiating into granule (gl) and Purkinje (pl) layers (Fig. 1, Fig. 2). In addition, we show that specific P2Y1 receptor staining is absent from NeuN-positive granule cell bodies, but present on the conspicuous array of fibers irradiating into the cerebellum and spreading out their projections to granular, Purkinje and molecular layers (Fig. 1). In sagital cerebellar sections, we see by confocal analysis that P2Y1 receptor immunoreactivity colocalizes with thick, straight and bundled neurofilament light chain (NFL) fluorescence, specific for neuronal processes (Fig. 2A), with tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine biosynthesis (Fig. 2B), and with dopamine beta-hydroxylase (DbetaH), specific for noradrenergic neurons (Fig. 3). We find that, differently from NFL (Fig. 2A), nerve fibers immunoreactive for both TH (Fig. 2B) or DbetaH (Fig. 3) and P2Y1 receptor can be much thinner (Fig. 3B, arrows), sparse, unbundled and winding and, moreover, display abundant varicosities and beaded appearance (Fig. 2B, inset c; Fig. 3B, arrow head and inset). Although P2Y1 receptor labeling is not uniformly distributed along the entire fiber, and not all DbetaH ramifications are P2Y1 positive, P2Y1 fibers are densely detected in the white matter of each cerebellar folium without distinction among lobules, sometimes in contact with perikarya (data not shown). At higher magnification and by triple immunofluorescence confocal analysis, we observe that a blue Calbindin-positive Purkinje axon is surrounded by yellow colocalizing signals of red P2Y1 receptor and green DbetaH (Fig. 3C). In this particular fiber, the P2Y1 receptor is absent from the Purkinje axon, but enriched on noradrenergic terminals on the same axon. Moreover, the numerous and large varicosities (1-3 mum diameter) of TH-positive fibers [20] directly express P2Y1 receptor (Fig. 2B, inset c) and are, therefore, likely responsible for the beaded appearance of P2Y1 receptor immunostaining. By triple immunofluorescence and confocal analysis on histological sections, we further prove that the P2Y1receptor-positive varicosities (red immunofluorescence) are enriched in synaptophysin (specific marker of synaptic structures, green immunofluorescence), and flotillin (a lipid rafts-associated integral membrane protein, blue immunofluorescence) [21], therefore providing a completely overlapping P2Y1-synaptophysin-flotillin immunoreactive signal (white immunofluorescence, Fig. 4). The large oval/cuboid staining (Fig. 4 insets), as well as the fine punctate staining, further demonstrate the presence of synaptophysin and P2Y1 receptor labeling on synaptic glomeruli.
###end p 13
###begin p 14
###xml 10 12 10 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Map of P2Y<sub>1 </sub>receptor protein in juvenile rat cerebellar cortex</bold>
###xml 194 196 194 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 581 583 581 583 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 41 44 <span type="species:ncbi:10116">rat</span>
###xml 88 91 <span type="species:ncbi:10116">rat</span>
Map of P2Y1 receptor protein in juvenile rat cerebellar cortex. Sagital sections of P21 rat cerebellar cortex were processed for double immunofluorescence analysis. Confocal images show that P2Y1 receptor protein (red immunofluorescence) is present on Purkinje cell (pc) bodies and ramifications, on neuropil of molecular layer (ml), on axons of the white matter irradiating into the granule layer (gl), but not on NeuN-positive granule neurons (blue immunofluorescence). The inset represents immunofluorescence analysis performed in the presence of the immunogenic peptide for P2Y1 receptor. Scale bars = 50 mum.
###end p 14
###begin p 15
###xml 19 21 19 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 0 40 0 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Localization of P2Y<sub>1 </sub>receptor on neurons</bold>
###xml 78 80 78 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 577 579 576 578 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 412 418 <span type="species:ncbi:9986">rabbit</span>
###xml 427 432 <span type="species:ncbi:10090">mouse</span>
Localization of P2Y1 receptor on neurons. Confocal images demonstrate that P2Y1 receptor immunoreactivity (red Cy3 immunofluorescence) colocalizes with NFL (green Cy2 immunofluorescence) specific for neuronal processes (A) and with TH (green Cy2 immunofluorescence) (B). The insets "a" and "b" in B, represent immunofluorescence analysis performed in the absence of the primary antibodies and only with the anti-rabbit or anti-mouse secondary antibodies, respectively. The inset "c" in B, shows large (1-3 mum diameter) varicosities present on TH-positive fibers expressing P2Y1 receptor (yellow immunofluorescence). Abbreviations: ml, molecular layer; pc, Purkinje cells; gl, granule layer. Scale bars are: 20 mum in A and B; 100 mum in the insets "a, b" in B; 5 mum in the inset "c" in B.
###end p 15
###begin p 16
###xml 19 21 19 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 0 47 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Localization of P2Y<sub>1 </sub>receptor on D&#946;H neurons</bold>
###xml 85 87 82 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 473 475 467 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Localization of P2Y1 receptor on DbetaH neurons. Confocal images demonstrate that P2Y1 receptor immunoreactivity (red Cy3 immunofluorescence) colocalizes with DbetaH, specific marker of noradrenergic neurons (green Cy2 immunofluorescence). In panel B, a higher magnification of sparse and unbundled noradrenergic fibers of different thickness (arrows) and beaded nature (arrow head and inset) is shown. Panel C represents a triple immunofluorescence performed with anti-P2Y1 receptor (red Cy3 immunofluorescence), anti-DbetaH (green Cy2 immunofluorescence), and anti-Calbindin-D-28K (blue immunofluorescence) antibodies. Scale bars are: 20 mum in A and B, and 5 mum in C and in the inset in B.
###end p 16
###begin p 17
###xml 24 26 24 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Beaded appearance of P2Y<sub>1 </sub>receptor immunostaining</bold>
###xml 205 207 205 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 512 513 512 513 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 75 78 <span type="species:ncbi:10116">rat</span>
###xml 190 196 <span type="species:ncbi:9986">Rabbit</span>
###xml 265 270 <span type="species:ncbi:10090">mouse</span>
###xml 360 365 <span type="species:ncbi:10090">mouse</span>
Beaded appearance of P2Y1 receptor immunostaining. Sagital sections of P21 rat cerebellar cortex were processed for triple immunofluorescence analysis and visualized by confocal microscopy. Rabbit anti-P2Y1 (red Cy3 immunofluorescence) was used in combination with mouse anti-synaptophysin, a marker for synaptic structures (green Cy2 immunofluorescence), and mouse anti-flotillin, a lipid rafts-associated integral membrane protein (blue immunofluorescence). In gl, the overlapping immunoreactive signals of P2Y1, synaptophysin and flotillin (arrows) can be distinguished by white immunofluorescence (arrows). Scale bars: 10 mum and 20 mum in the insets.
###end p 17
###begin p 18
###xml 22 24 22 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
On the other hand, P2Y1 receptor does not colocalize with glial fibrillary acidic protein (GFAP), therefore excluding its concurrent expression on astrocytes (Fig. 8B, lower-right inset).
###end p 18
###begin title 19
###xml 43 45 43 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Ultrastructural analysis indicates that P2Y1 receptor is present on both axon terminals and dendrites
###end title 19
###begin p 20
###xml 58 60 58 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 161 163 161 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 331 333 331 333 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 535 537 535 537 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 594 595 594 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 695 696 695 696 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 870 872 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 877 879 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 1051 1055 1050 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A&#8211;C</xref>
###xml 1065 1067 1064 1066 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1171 1175 1170 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A&#8211;C</xref>
###xml 1199 1201 1198 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6E</xref>
###xml 1276 1278 1275 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 1384 1386 1383 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6F</xref>
###xml 1443 1445 1442 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 1454 1456 1453 1455 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 231 234 <span type="species:ncbi:10116">rat</span>
To further investigate the subcellular localization of P2Y1 protein, we performed ultrastructural analysis by electron microscopy. We confirm the presence of P2Y1 receptor immunoreactive profiles in all cortical layers of juvenile rat cerebellar cortex, although more abundantly in gl (Fig. 5A), rather than pl or ml (Fig. 5B). P2Y1 receptor immunoreactivity is moreover present on both dendrites (Fig. 5A, asterisks) and fine, beaded axons (Fig. 5A, white circle, Fig. 5B, arrows) that travel along the cerebellar cortical layers. P2Y1 immunoreactive axons are un-myelinated and consist of P2Y1-positive small axonal enlargements or varicosities (Fig. 5C, black arrow) connected by narrower P2Y1-positive inter-varicose segments (Fig. 5C, white arrow). The varicosities are about 1-2 mum in diameter and filled with synaptic pleomorphic vesicles and mitochondria (Fig. 5C and 5D). Intervaricose segments do not contain vesicles. The most remarkable feature of the electron microscopy analysis is the absence of visible synaptic specializations (Fig. 6A-C). The P2Y1 receptor-positive varicosities are in fact adjacent to cerebellar elements like granule dendrites (Fig. 6A-C) and cell bodies (Fig. 6E), without formation of conventional synaptic junctions (see arrow in Fig. 6C). In addition, specific immunolabelling is observed also in proximal dendrites of Purkinje neurons (Fig. 6F), and very rarely in cell bodies of granule cells (Fig. 6D). No P2Y1 receptor-immunolabelled glial cells are observed.
###end p 20
###begin p 21
###xml 35 37 35 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 0 82 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Electron microscopy analysis of P2Y<sub>1 </sub>receptor on both axon terminals and dendrites</bold>
###xml 93 95 93 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 229 231 229 231 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 366 368 366 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Electron microscopy analysis of P2Y1 receptor on both axon terminals and dendrites. In A, P2Y1 receptor immunolabelling is shown on varicosities of fibers (white circle) and dendrites of granule cells (white asterisks). In B, P2Y1 receptor immunolabelled varicosities (black arrows) are shown apposed to neuronal elements such as dendrites and cell bodies. In C, P2Y1 receptor immunolabelled varicosity (black arrow) contains mitochondria and pleomorphic vesicles, whereas the intervaricose segment (white arrow) is deprived of vesicles. In D, the varicosity is shown to be filled with pleomorphic vesicles, without forming a clear synaptic contact. Scale bars = 2 mum in A; 2,5 mum in B; 1 mum in C and D.
###end p 21
###begin p 22
###xml 35 37 35 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 0 88 0 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Electron microscopy analysis of P2Y<sub>1 </sub>receptor on synaptic terminals forming varicosities</bold>
Electron microscopy analysis of P2Y1 receptor on synaptic terminals forming varicosities. In A, labelled varicosities are apposed to neuronal elements of cerebellar cortical layers, mostly dendrites in granule cell layer. In a few cases, the immunoreactivity is so strong to cover the vesicles of the terminal. In B, the features of the varicosities are unchanged also in Purkinje cell layer. In C, the absence of synaptic junctions is clearly visible (see arrow). In D, the granule cell shows specific labelling in the cytoplasm (n = nucleus of granule cell). In E, a few granule cells (GC) are labeled, being on the contrary apposed to immunolabeled terminals. In F, also Purkinje neurons are immunolabeled, especially proximal dendrites (D). Scale bar in A-C = 1 mum; in D = 1,2 mum; in E and F = 0,8 mum.
###end p 22
###begin title 23
###xml 3 5 3 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
P2Y1 receptor localizes in lipid rafts and synaptosomes
###end title 23
###begin p 24
###xml 84 86 84 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 286 288 286 288 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 341 343 341 343 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 597 599 597 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 1004 1006 1004 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1071 1073 1071 1073 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1231 1235 1231 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A,B</xref>
###xml 1363 1365 1363 1365 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1478 1480 1478 1480 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 220 223 <span type="species:ncbi:10116">rat</span>
###xml 1480 1485 <span type="species:ncbi:9606">human</span>
Since fluorescence microscopy indicated a high degree of co-localization between P2Y1 receptor and the lipid rafts marker flotillin-2, we purified low buoyant density detergent-resistant membranes (lipid rafts) from P21 rat cerebellum, in order to better dissect the localization of P2Y1 protein. Whereas in total cerebellar extracts the P2Y1 receptor is recognized as a major protein band of approximately 120 kDa and a minor band of about 42 kDa (molecular mass expected from aminoacid sequence analysis) (Fig. 7A), the specific form recognized in the absence of the antigenic peptide by the P2Y1 receptor antiserum in the low density fractions of the sucrose gradient (together with the lipid rafts marker flotillin-2) corresponds not to the monomeric, but to the oligomeric protein (Fig. 7B). This is not surprising, since SDS-resistant oligomeric forms of this receptor are frequently reported, for instance in vascular smooth muscle and endothelial cells, and suggested to be the functional forms [22]. Consistently, when the receptor antiserum used to identify P2Y1 protein is pre-incubated with the immunizing peptide, the reactivity not only to the monomeric, but also to the oligomeric band is completely abolished (Fig. 7A,B), therefore confirming the specificity of the antigen-antiserum interactions. This is further proved by the result that the P2Y1 receptor polyclonal antiserum used in this study is able to efficiently immunoprecipitate the recombinant Myc-P2Y1 human receptor transiently transfected in SH-SY5Y cells and detected by the anti-myc 9E10 antibody (data not shown).
###end p 24
###begin p 25
###xml 3 5 3 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 0 38 0 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink">P2Y<sub>1 </sub>receptor localizes in lipid rafts</bold>
###xml 302 304 301 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 552 554 551 553 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 72 76 <span type="species:ncbi:10116">rats</span>
###xml 543 547 <span type="species:ncbi:10116">rats</span>
P2Y1 receptor localizes in lipid rafts. Cerebella were removed from P21 rats and cell protein extracted in lysis buffer for 30 min on ice. Supernatants obtained after a centrifugation for 10 min at 15000 x g were loaded on SDS-PAGE (100 mug/lane), transferred to nitrocellulose and probed with anti-P2Y1 receptor antiserum, in the absence (-) or presence (+) of the immunogenic peptide (A). Lipid rafts-enriched fractions were then prepared from total cerebellar tissue (B) or from purified cerebellar synaptosomes (C), both obtained from P21 rats. P2Y1 receptor is recovered in rafts fractions 3 (B), in the absence of the immunogenic peptide, or 4-7 (C), together with the selective lipid rafts markers flotillin-2 (B, C) or GM1 (C), but not the transferrin receptor (C), a protein known to be excluded from lipid microdomains.
###end p 25
###begin p 26
###xml 92 94 92 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 127 128 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 272 274 272 274 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 331 333 331 333 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
Since fluorescence microscopy also demonstrated a high degree of co-localization between P2Y1 receptor and synaptophysin (Fig. 4), fractions were also prepared directly from cerebellar synaptosomes, in order to confirm the synaptic localization of lipid rafts-resident P2Y1 receptor. Our results again demonstrate that only the P2Y1 receptor oligomer is present in synaptosomal lipid rafts-enriched fractions (Fig 7C), together with the lipid rafts markers flotillin-2 and GM1ganglioside (fractions 4-7). Neither monomer nor oligomer receptor is instead detected in the high density synaptosomal fractions (fractions 10-12) containing transferrin receptor, a protein known to be excluded from lipid rafts microdomains.
###end p 26
###begin title 27
###xml 32 34 32 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
The phenotypic expression of P2Y1 receptor switches during cerebellar development
###end title 27
###begin p 28
###xml 42 44 42 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 358 360 358 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 460 462 460 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 828 830 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 836 838 836 838 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 909 911 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
###xml 1123 1125 1120 1122 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1149 1151 1146 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 1178 1180 1175 1177 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1391 1393 1388 1390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1456 1458 1453 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 1522 1523 1519 1520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1525 1526 1522 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1528 1529 1525 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1565 1567 1562 1564 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
We next investigated the expression of P2Y1 receptor at postnatal day 7 (P7), when the maturation of synapses is just taking place between granule neuron dendrites and fiber terminals [23], and the internal granular layer (igl) rapidly expands beneath the monocellular sheet of pc. With the only exception of calbindin-positive pc (Fig. 8A), we find that P2Y1 receptor localization is completely different from that observed at P21 (Fig. 8A, inset). At P7, P2Y1 receptor immunoreactivity is indeed absent from noradrenergic fibers of white matter, but predominantly shown: a) on fibers irradiating the thin ml (above the pl) and the external granule (or germinal) layers (egl) (Fig. 8B); b) on cell bodies aligned at the interface between the pc and ml (Fig. 8B, upper-left inset); c) on isolated cells located in the igl (Fig. 8B). P2Y1 receptor immunostaining is thus totally absent from NFL-positive (Fig. 8C) and TH- or DbetaH-positive fibers (data not shown), which already span into the gl at this age of development. By means of distinctive morphology of cerebellar astrocytes and positive colocalization between P2Y1 receptor and GFAP (Fig. 8B), at P7 we do identify P2Y1 receptor on both Bergmann cell bodies/fibers and astroglial cells scattered among granule neurons. This is confirmed for postnatal day one (data not shown), but is the opposite of what was shown at P21, when P2Y1 receptor is totally absent from GFAP-positive structures (Fig. 8B, lower-right inset) and present only on neuronal fibers (Figs. 2, 3, 4). Conversely, the enrichment of P2Y1 receptor in lipid rafts, but not synaptosomal fractions, is confirmed also at P7 (data not shown), therefore appearing as a conserved feature of this receptor.
###end p 28
###begin p 29
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 504 505 504 505 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 764 765 764 765 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 968 969 968 969 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 988 990 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 1079 1081 1079 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 1240 1241 1240 1241 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1278 1280 1278 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 1407 1409 1407 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1489 1491 1489 1491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
###xml 1507 1509 1507 1509 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1563 1565 1563 1565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 1593 1595 1593 1595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
It's well known that, during development, Bergmann fibers are associated with migrating granule cells, from which is derived the concept of glia-guided neuronal migration [24], and that DCX is a distinctive marker of granule cells only during the period of radial descent into the deep cerebellar layers, when it directs neuronal movement through the organization and stability of microtubules [25]. Therefore, we used DCX immunoreactivity to observe the potential relationship between Bergmann glia (P2Y1-positive only at neonatal ages P1-P7) and granule neurons. We find that at P7, the DCX-positive signal appears as a diffuse labeling on both the entire igl and the thin ml enriched in radially migrating granule cells, but is excluded by the pre-migratory P2Y1-expressing egl (Fig. 9A). Given the high density, amoeboid shape and lack of defined neuronal contour of migrating granule cells at this neonatal age, the DCX-positive staining appears contiguous to P2Y1-GFAP fibers (Fig. 9A inset), providing an almost overlapping signal when observed at low magnification (Fig. 9A, yellow fluorescence). Nevertheless, at higher resolution it is possible to distinguish that DCX-positive granule cells are wrapped up and stretched along P2Y1-GFAP-positive Bergmann fibers (Fig. 9A inset). On the opposite, when at P21 the egl almost disappears after complete proliferation and migration of granule neurons [23], the DCX immunostaining is confined to a very narrow zone below the pc (Figs. 9B, inset) and P2Y1 receptor is no longer detected on Bergmann glia (Fig. 8B lower-right inset and Fig. 9B).
###end p 29
###begin p 30
###xml 10 12 10 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 0 78 0 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Map of P2Y<sub>1 </sub>receptor protein in neonatal versus juvenile rat cerebellar cortex</bold>
###xml 249 251 249 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 679 681 679 681 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 917 919 917 919 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 57 60 <span type="species:ncbi:10116">rat</span>
###xml 164 167 <span type="species:ncbi:10116">rat</span>
###xml 169 171 <span type="species:ncbi:10116">P7</span>
###xml 242 244 <span type="species:ncbi:10116">P7</span>
Map of P2Y1 receptor protein in neonatal versus juvenile rat cerebellar cortex. Double immunofluorescence visualized by confocal analysis was performed in neonatal rat (P7) cerebellar cortex and compared to that at P21 (inset in panel A). At P7, P2Y1 receptor immunoreactivity (red Cy3 immunofluorescence) is present on calbindin-positive pc (green Cy2 immunofluorescence), on fibers irradiating from the thin ml toward the egl (A, B), on cell bodies at the interface between the pl and ml (black arrow in the left inset of panel B), and on isolated cells situated in the igl (white arrows in panel B). Double immunofluorescence (yellow) shows complete colocalization between P2Y1 (red Cy3 immunofluorescence) and GFAP (green Cy2 immunofluorescence) signals (white arrows in B; black and white arrows in the upper-left inset of panel B), differently from what observed at P21 (lower-right inset of panel B). In C, P2Y1 (red Cy3 immunofluorescence) and NFL (green Cy2 immunofluorescence) immunostaining are shown. Abbreviations: egl, external granule layer; gl, granule layer; igl, internal granule layer; ml, molecular layer; pc, Purkinje cells. Scale bar = 20 mum in A, B and C; 50 mum in the inset in A; 10 mum in the upper-left inset in B; 40 mum in the lower-right inset in B.
###end p 30
###begin p 31
###xml 3 5 3 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">P2Y<sub>1 </sub>receptor and migrating granule neurons</bold>
###xml 106 108 106 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 220 223 <span type="species:ncbi:10116">rat</span>
###xml 227 229 <span type="species:ncbi:10116">P7</span>
P2Y1 receptor and migrating granule neurons. Confocal images of DCX (green Cy2 immunofluorescence) and P2Y1 (red Cy3 immunofluorescence, white arrows in the inset of panel A) are shown from cerebellar cortex of neonatal rat at P7 (A) and P21 (B). Abbreviations: egl, external granule layer; gl, granule layer; igl, internal granule layer; ml, molecular layer; pc, Purkinje cells. Scale bar = 50 mum in A and B; 10 mum, in the inset in A and B.
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 136 138 136 138 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 293 295 293 295 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 872 874 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 880 882 880 882 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1321 1323 1318 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1355 1357 1352 1354 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1590 1592 1587 1589 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1770 1772 1767 1769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 2207 2209 2204 2206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 2274 2276 2271 2273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 2306 2307 2303 2304 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 2442 2444 2439 2441 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 2591 2593 2588 2590 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 2807 2809 2804 2806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 441 443 <span type="species:ncbi:10116">P7</span>
###xml 788 791 <span type="species:ncbi:10116">rat</span>
###xml 1315 1318 <span type="species:ncbi:10116">rat</span>
The main goal of our study was to characterize the cellular and subcellular distribution and features of the purinergic metabotropic P2Y1 receptor in the cerebellum, and to gain insights on its potential function during development of the cerebellar circuitry. To this purpose, we analyzed P2Y1 receptor expression at P21, when the major structural changes already took place in the developing cerebellum, and compared it with expression at P7, when migration of granule neurons from the molecular to the granular layer is still occurring [23,26,27], and when the neuronal bodies in the locus coeruleus of origin for the dorsal bundle of noradrenergic neurons innervating the cerebellum are spreading out their projections to the granular, Purkinje and molecular layers [28]. In juvenile rat cerebellum we find that, in addition to Purkinje cell bodies and ramifications [12], P2Y1 receptor is abundant on neuronal specializations identified as noradrenergic by anatomical (the fibers travel in linear, sparse and different thickness profiles through the gl, and branch into radially and longitudinally oriented chains), ultrastructural (abundance of synaptic varicosities and winding, beaded appearance) and biochemical features (immunoreactivity with noradrenergic-specific DbetaH absent from Purkinje neurons in rat) [29]. Moreover, we observe that P2Y1 receptor is preferentially localized on synaptic varicosities of the noradrenergic fibers and synaptic glomeruli, which can be recognized by the presence of synaptophysin. The ultrastructural analysis confirms the localization of P2Y1 receptor on varicosities of axon terminals, moreover showing features indicative of a particular modality of transmitter release. As generally reported for noradrenergic fibers [30], the absence of conventional synaptic junctions led us to suppose that in the cerebellum also extracellular nucleotides might exert their modulatory action through paracrine release or simple diffusion in the extracellular space. This modality has the advantage to extend the potential effects of extracellular nucleotides, and neurotransmitters in general, to structures equipped with adequate receptors (extra-synaptic receptors) [31], but distant from the source of release (volume transmission) [32]. The enrichment in these P2Y1-positive varicosities of both synaptophysin and the lipid rafts marker flotillin-2 (together with the biochemical observation that P2Y1 receptor is indeed a lipid rafts-resident protein in total cerebellar tissue and cerebellar synaptosomes) furthermore suggests that the role of P2Y1 receptor is likely mediated by lipid microdomains. In this regard, it is already well-known that lipid rafts display a key part in the targeting and functional organization of proteins at both synapses and spines [33].
###end p 33
###begin p 34
###xml 159 161 159 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1037 1039 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1229 1231 1229 1231 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Since a further specification of the central noradrenergic system consists in the frequency of co-transmission phenomena, the presence in the cerebellum of P2Y1 receptor on noradrenergic neurons in addition to Purkinje cells might signify that extracellular nucleotides such as the natural agonists ATP and ADP could contribute in this brain region to the physiological role of noradrenaline [34]. In this regard, ATP is already well known to be co-released with noradrenaline in various PNS and CNS neurons [35,36]. Thus, if co-release and synergism occur at cerebellar synapses as well, nucleotide-dependent increase of cerebellar noradrenergic signaling could be achieved. Homologous recombination techniques have shown that complete removal of either the enzymes responsible for noradrenaline metabolism or the vesicular monoamine transporter has deleterious consequences for foetal survival [37]. Moreover, blockade of postsynaptic noradrenergic receptors decreases the rate of learning in several cerebellar-dependent motor tasks [38]. The possibility of integrating and complementing noradrenergic with purinergic mechanisms to increase the strength of synaptic connections through activation of both noradrenergic and P2Y1 receptors might therefore constitute also a novel powerful approach against neuronal degeneration and/or malfunctioning in the cerebellum.
###end p 34
###begin p 35
###xml 19 21 19 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 189 191 189 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 892 894 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 963 965 963 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 966 968 966 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1163 1165 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1177 1179 1177 1179 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1447 1448 1447 1448 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1468 1471 1468 1471 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 1501 1503 1501 1503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1652 1654 1652 1654 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1725 1727 1725 1727 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1982 1984 1982 1984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 2326 2328 2326 2328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 2432 2434 2432 2434 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 2451 2453 2451 2453 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 43 46 <span type="species:ncbi:10116">rat</span>
###xml 303 305 <span type="species:ncbi:10116">P7</span>
###xml 2387 2390 <span type="species:ncbi:10116">rat</span>
The presence of P2Y1 receptor in postnatal rat cerebellum was then analyzed before the formation of noradrenergic synaptic connections takes place. Surprisingly, we have shown here that P2Y1 undergoes a drastic switch during development, with a phenotypic expression resembling that of Bergmann glia at P7, rather then noradrenergic neurons at P21. In this regard, it is well established that a number of neuronal and glial receptor systems and/or diffusible factors act to induce and maintain Bergmann glia process extension at an early stage of postnatal development [39-41], when Bergmann cells specialize in supporting the migration of granule neurons and migration of granule cells seems to be largely dependent on their interaction with glial processes [42,43]. In particular, the ErbB4 tyrosine kinase receptor present on Bergmann glia appears to have a distinct role in this process [44], interacting with neoregulin expressed on migrating granule cells [45,46]. On the other hand, in vitro studies on the migration of granule neurons demonstrated that the glycoprotein astrotactin provides a neuronal receptor system for migration along glial processes [47]. Thus, P2Y1 receptor expression only on Bergmann glia at an early stage of development might sustain a role for purinergic receptors in signaling events needed for interaction and migration of neurons. This is strongly supported by the result that ADP, preferential ligand for P2Y1receptor, induces Ca2+ mobilization in Bergman glia [48]. The factors produced by granule neurons to induce the glial scaffold might thus comprise the purinergic ligands ATP and ADP directly targeting P2Y1 receptors. To support this hypothesis, we have both shown here that P2Y1 receptor is localized at the interface between Bergmann glia and DCX-positive migrating granule cells, and previously demonstrated that, at least in vitro, granule neurons can release ATP, which is easily degraded to ADP in the extracellular environment [49]. It is finally well known that, once migration across the glia scaffold is completed and cells change their repertoire of adhesive molecules and switch into a static asset: a) the Bergmann glia loses the apposition with granule neurons; b) the granule cells are locked in position by the formation of new specific axon-target interactions [46]. In parallel, we have demonstrated here that in juvenile rat cerebellum: a) the Bergmann glia lose P2Y1 receptors; b) P2Y1 receptors appear on Purkinje and noradrenergic neurons forming new specific axon-target interactions.
###end p 35
###begin title 36
Conclusion
###end title 36
###begin p 37
###xml 188 190 188 190 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 299 301 299 301 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 414 416 414 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Since membrane components of the cell surface are largely known to mediate the close apposition between two cells during all phases of development, our results suggest a novel role for P2Y1 receptor in the CNS, specifically in cell junction/communication. This already occurs on platelets, where P2Y1 receptor is well known to mediate cell contact and aggregation [50-52]. Considering the glia-neuron switch of P2Y1 receptor a novel biological mechanism of development, aim of further studies will be to investigate the potential impact of this receptor on Bergman glia-guided migration of granule neurons; on alteration/reorganization of noradrenergic fibers in the cerebellar cortex in response to the degeneration of their major target, granule and Purkinje neurons; and finally to investigate if the presence of purinergic ligands in the environment surrounding noradrenergic fibers can influence their anatomical integrity and development.
###end p 37
###begin title 38
Methods
###end title 38
###begin title 39
Histological procedures
###end title 39
###begin p 40
###xml 0 11 <span type="species:ncbi:10116">Wistar rats</span>
Wistar rats (Harlan, Udine, Italy) of different ages were deeply anesthetized by i.p. injections of sodium pentobarbital (60 mg/kg), and transcardially perfused with saline (0.9% NaCl) followed by 4% paraformaldehyde, in phosphate buffer (PB, 0.1 M pH 7.4). Each brain was immediately removed, post-fixed in the same fixative for 2 hs, and then transferred to 30% sucrose in PB at 4degreesC, until it sank. The experimental protocol used in this study was approved by the Italian Ministry of Health and was in agreement with the guidelines of the European Communities Council Directive of November 24, 1986 (86/609/EEC) for the care and use of laboratory animals. All efforts were made to minimize the number of animals used and their suffering.
###end p 40
###begin title 41
Double immunofluorescence
###end title 41
###begin p 42
###xml 396 398 395 397 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 179 185 <span type="species:ncbi:9793">donkey</span>
###xml 381 387 <span type="species:ncbi:9986">Rabbit</span>
###xml 469 474 <span type="species:ncbi:10090">mouse</span>
###xml 522 527 <span type="species:ncbi:10090">mouse</span>
###xml 574 579 <span type="species:ncbi:10090">mouse</span>
###xml 675 680 <span type="species:ncbi:10090">mouse</span>
###xml 741 746 <span type="species:ncbi:10090">mouse</span>
###xml 782 786 <span type="species:ncbi:9925">goat</span>
###xml 844 848 <span type="species:ncbi:9925">goat</span>
###xml 974 980 <span type="species:ncbi:9793">donkey</span>
###xml 986 992 <span type="species:ncbi:9986">rabbit</span>
###xml 1099 1105 <span type="species:ncbi:9793">donkey</span>
###xml 1111 1116 <span type="species:ncbi:10090">mouse</span>
###xml 1197 1203 <span type="species:ncbi:9793">donkey</span>
###xml 1209 1213 <span type="species:ncbi:9925">goat</span>
###xml 1444 1450 <span type="species:ncbi:9793">donkey</span>
Sagital sections (40 mum thick) were cut on a freezing microtome and were processed for double immunofluorescence studies. Non-specific binding sites were blocked with 10% normal donkey serum in 0.3% Triton X-100, in phosphate buffered saline (PBS) for 30 min at room temperature. The sections were incubated in a mixture of primary antisera for 24 hs in 0.3% Triton X-100 in PBS. Rabbit anti-P2Y1 (1:500, Alomone, Jerusalem-Israel) was used in combination with either mouse anti-Calbindin-D-28K (1:200, Sigma, Mi-Italy), mouse anti-Tyrosine Hydroxylase (TH, 1:500, Sigma), mouse anti-Dopamine beta-Hydroxylase (DbetaH, 1:500, Chemicon International, Inc. Temecula, CA-USA), mouse anti-Glial Fibrillary Acidic Protein (GFAP) (1:400, Sigma), mouse anti-Synaptophysin (1:100, Sigma), goat anti-Doublecortin (DCX, 1:200, Santa Cruz, Mi-Italy), or goat anti-NFL (Neurofilament-L protein, 1:100, Santa Cruz). The secondary antibodies used for double labeling were Cy3-conjugated donkey anti-rabbit IgG (1:100, Jackson Immunoresearch, West Baltimore Pike, PA, USA, red immunofluorescence), Cy2-conjugated donkey anti-mouse IgG (1:100, Jackson Immunoresearch, green immunofluorescence) or Cy2-conjugated donkey anti-goat IgG (1:100, Jackson Immunoresearch, green immunofluorescence). The sections were washed in PBS three times for five min each, and then incubated for 3 hs in a solution containing a mixture of the secondary antibodies in 1% normal donkey serum in PBS. After rinsing, the sections were mounted on slide glasses, allowed to air dry and coverslipped with gel/mounttrade mark anti-fading medium (Biomeda, Foster City, CA-USA).
###end p 42
###begin title 43
Triple immunofluorescence
###end title 43
###begin p 44
###xml 307 309 307 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 351 353 351 353 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 388 390 388 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 694 696 694 696 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 193 198 <span type="species:ncbi:10090">mouse</span>
###xml 298 303 <span type="species:ncbi:10090">mouse</span>
###xml 342 347 <span type="species:ncbi:10090">mouse</span>
###xml 379 384 <span type="species:ncbi:10090">mouse</span>
###xml 476 481 <span type="species:ncbi:10090">mouse</span>
###xml 525 530 <span type="species:ncbi:10090">mouse</span>
###xml 590 595 <span type="species:ncbi:10090">mouse</span>
###xml 685 690 <span type="species:ncbi:10090">mouse</span>
###xml 790 795 <span type="species:ncbi:10090">mouse</span>
###xml 991 996 <span type="species:ncbi:10090">mouse</span>
After double immunofluorescence, the sections were mounted on slide glasses, and allowed to air dry. A rectangle was then drawn around the sections with a PAP pen. To allow the use of a second mouse antibody in the same immunolabeling protocol, the unlabeled monoclonal anti-NeuN (Neuronal Nuclei, mouse IgG1 isotype or anti-Calbindin-D-28K (mouse IgG1 isotype)) or Flotillin-2 (mouse IgG1 isotype) were labeled with Zenon technology (Molecular Probes, Oregon, USA). Briefly, mouse anti-NeuN (1:100, Chemicon International), mouse anti-Flotillin-2 (1:100, BD Biosciences, San Jose, CA) and mouse anti-Calbindin-D-28K (1:200, Sigma) were separately incubated with Zenon Alexa Fluor 647 mouse IgG1 labeling reagent (molar ratio 6:1), which contains a fluorophore-labeled (Ex/Em 650/668) anti-mouse Fab fragments. The labeled Fab fragments bind to the Fc portion of the monoclonal antibodies and excess Fab fragments are neutralized by the addition of a nonspecific IgG (Zenon blocking reagent-mouse IgG). The addition of non-specific IgG prevents cross-labeling of the Fab fragment, in experiments where multiple primary antibodies of the same type are present. After rehydration in PBS, the sections were incubated with the staining solution in PBS containing 0.5% Triton X-100 (PBT) in a humidified chamber for 2 hs at room temperature. The sections were washed twice in PBT and for 5 min in PBS at room temperature. Sections were then fixed in 4% paraformaldehyde in PB for 15 min at room temperature, to avoid the dissociation of the Zenon Fab fragment from the primary antibody, washed three times with PBS, allowed to air dry and coverslipped with gel/mount anti-fading medium.
###end p 44
###begin title 45
Confocal microscopy
###end title 45
###begin p 46
###xml 519 521 519 521 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 599 601 599 601 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 431 437 <span type="species:ncbi:9986">rabbit</span>
###xml 446 451 <span type="species:ncbi:10090">mouse</span>
Double or triple label immunofluorescence was analyzed by means of a confocal laser scanning microscope (CLSM) (LSM 510, Zeiss, Arese Mi-Italy) equipped with argon laser emitting at 488 nm, helium/neon laser emitting at 543 nm, and helium/neon laser emitting at 633 nm. Specificity of the antibodies was positively proved by performing confocal analysis in the absence of the primary antibodies, but in the presence of either anti-rabbit or anti-mouse secondary antibodies. Specificity was further confirmed for the P2Y1 antiserum by performing immunoreactions in the simultaneus presence of the P2Y1 neutralizing immunogenic peptide.
###end p 46
###begin title 47
Electron microscopy sample preparation
###end title 47
###begin p 48
###xml 419 421 418 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 708 710 707 709 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 735 736 734 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1299 1300 1292 1293 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1301 1302 1294 1295 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
###xml 576 580 <span type="species:ncbi:9925">goat</span>
###xml 720 726 <span type="species:ncbi:9986">rabbit</span>
###xml 872 876 <span type="species:ncbi:9925">goat</span>
###xml 882 888 <span type="species:ncbi:9986">rabbit</span>
Rats (n = 4) were anaesthetised with chloral hydrate (400 mg/kg i.p.), perfused through the ascending aorta with a solution of NaCl 0.9% for 5 min, then followed by 3% paraformaldehyde with 0.4% glutaraldehyde in PB for 30 min. Cerebella were dissected and sagittal sections were cut at 40 mum, and washed several times in PBS. Sections were treated with sodium borohydrate (Sigma) 0.1% in PBS. Immunoreactivity for P2Y1 receptor was detected by means of the avidin-biotin peroxidase method. Briefly, sections from the cerebellum were pre-blocked in a solution containing 10% goat serum in PB for 30 min at room temperature. Then, sections were incubated in a solution containing primary antibody against P2Y1 receptor (rabbit anti-P2Y1diluted 1:200) in PB for 24 hs at 4degreesC. After several washes in PBS, sections were incubated with biotinylated secondary antibody (goat anti-rabbit diluted 1:100 Vectastain Elite, Vector Laboratories, Peterborough, UK) in PB for 3 hs at room temperature. They were then incubated in avidin-biotin peroxidase complex (diluted 1:100 in PB; Vectastain Elite, Vector Labs.) for 1 h. After washing, immunolabeling was revealed by incubation of the sections in 0.05% 3,3'-diaminobenzidine solution (DAB-Sigma) diluted in Tris-HCl buffer, in the presence of 0.01% H2O2. The reaction was stopped by several washes in Tris-HCl buffer followed by PBS. Sections were post-fixed in osmium tetroxide (1% in PB) for 10 min, dehydrated in ascending series of dilution of ethanol (with the presence of 1% uranyl acetate in 70% ethanol) followed by propylene oxide (Aldrich, MI, Italy) and then embedded overnight in resin (Durcupan ACM-Fluka, Gillingham, Dorset, UK), mounted on glass slides and then cured at 60degreesC for 48 hs. The areas of interest were examined in the light microscope, cut from the sections and 60 nm ultra-thin sections were obtained with an ultramicrotome (Reichert-Jung Ultracut E, Leica, Nussloch, Germany), and collected on 400-mesh copper grids, counterstained with lead citrate and examined using a Zeiss EM900 electron microscope. Controls were performed omitting the primary antibody from the procedure.
###end p 48
###begin title 49
Electron microscopy data analysis
###end title 49
###begin p 50
###xml 324 326 324 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 847 849 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 489 493 <span type="species:ncbi:10116">rats</span>
The ultrastructural analysis was performed exclusively on the most superficial portions of the tissue in contact with the embedding plastic, in order to minimize artificial differences in labeling attributed to potential differences in the penetration reagents. Regions used for this analysis were chosen on the basis of P2Y1 receptor immunoreactivity and the morphological integrity of the tissue. The labelled profiles were examined in thirty-two ultra-thin sections from three separate rats, in four sections each taken from the vermis, the cerebellar hemispheres and the cerebellar nuclei. Electron micrographs of immunoreactive structures were taken at magnifications of 7000-30000 X, then printed and used as the sampling region of each block. The classification of neuronal elements was made according to the description of Peters et al., [53]. Neuronal somata were identified by the nucleus, Golgi apparatus, and rough endoplasmic reticulum; un-myelinated axons were distinguished from dendrites by their larger diameter and/or the abundance of uniformly distributed microtubules and synaptic inputs from axon terminals. Neuronal profiles were classified as un-myelinated axons if they were 0.1-0.25 mum in cross sectional diameter and contained microtubules and/or small vescicles. Axon terminals were defined as elements 0.25 mum or larger in diameter containing numerous small synaptic vescicles. Synapses formed by axon terminals were defined as asymmetric, when their post-synaptic density was thicker that the pre-synaptic one, and as symmetric, when both membranes showed equal electron density. Two structures were considered adjacent, when the two plasma membranes were parallel and not separated by glial processes, but no membrane specialization was visible.
###end p 50
###begin title 51
Preparation of low density membrane fractions
###end title 51
###begin p 52
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 198 199 198 199 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c</sub>
###xml 173 184 <span type="species:ncbi:10116">Wistar rats</span>
Detergent-insoluble glycolipid fractions were prepared following an established method [54], with minor modifications [55]. Briefly, cerebella were removed from 21 days old Wistar rats, cut with a McIlwain tissue chopper (400 mum) in two orthogonal directions and resuspended in 10 volumes (w/v) of ice-cold lysis buffer (10 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 2 mM EDTA, 1 mM PMSF, 20 muM Leupeptin) by vortexing. After 30 min, the lysate was centrifuged at 2000 x g for 10 min, to remove nuclei and large debris. The resulting supernatant (500 mul, 2-2.5 mg) was mixed with an equal volume of 85% sucrose in TBS (10 mM Tris-HCl pH 7.5, 150 mM NaCl), and placed at the bottom of the centrifuge tube. A volume of 700 mul of 35% sucrose in TBS and 400 mul of 5% sucrose were layered on the top of the lysate. The gradient was centrifuged for 14 hs at 200.000 x g in a TLS 55 rotor (Beckman Instruments, Porterville, CA). Four fractions of 150 mul and five fractions of 300 mul were collected from the top of the tube. The entire procedure was performed at 4degreesC. Equal volumes, containing a range of approximately 0.5-100 mug of total protein depending on the fraction, were loaded on SDS-PAGE electrophoresis.
###end p 52
###begin title 53
Synaptosome Triton X-100 solubilization and sucrose floatation gradients
###end title 53
###begin p 54
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 32 35 <span type="species:ncbi:10116">rat</span>
Synaptosomes were obtained from rat cerebella by means of differential centrifugation, as previously described [56]. Briefly, post-nuclear supernatants were centrifuged at 9200 x g for 15 min to yield a pellet corresponding to partially purified synaptosomes. These pellets (6 mg of proteins) were resuspended in 0.75 ml of buffer A (150 mM NaCl, 2 mM EGTA, 50 mM Tris-HCl, pH 7.5, protease inhibitors) containing 1% (w/v) Triton X-100. After 30 min on ice, each sample was adjusted to 1.2 M sucrose, placed in a centrifuge tube and overlaid with a linear gradient ranging from 30 to 5% sucrose (all prepared in buffer A). The gradients were centrifuged at 190000 x g for 19 hs using a rotor SW 41 Ti (Beckman Instruments). Fifteen fractions (0.8 ml each), and the pellets resuspended in 0.8 ml of buffer A were collected and analysed by means of SDS-PAGE and western blotting. The sucrose concentration in each fraction was determined by refractometry.
###end p 54
###begin title 55
Western blot analysis
###end title 55
###begin p 56
###xml 344 346 344 346 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 329 335 <span type="species:ncbi:9986">rabbit</span>
###xml 363 368 <span type="species:ncbi:10090">mouse</span>
###xml 408 419 <span type="species:ncbi:3704">horseradish</span>
Equal amount of sucrose gradient samples was separated by electrophoresis on 10%-12% SDS-PAGE and transferred to nitrocellulose membranes Hybond-C extra (Amersham Biosciences, Cologno Monzese, Italy). The filters were pre-wetted in 5% non-fat milk in TBS-T (10 mM Tris pH 8, 150 mM NaCl, 0.1%Tween 20), hybridized overnight with rabbit anti-P2Y1 (1:400) and with mouse anti-Flotillin-2 (1:1000), followed by horseradish peroxidase-coupled secondary antibody, and analysed by ECL chemiluminescence (Amersham Biosciences), using Kodak Image Station (KDS IS440CF).
###end p 56
###begin title 57
###xml 8 10 8 10 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Anti-P2Y1 specificity
###end title 57
###begin p 58
###xml 18 20 18 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 73 75 73 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 289 291 289 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 293 296 293 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">rd </sup>
###xml 343 345 343 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 528 530 528 530 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 625 627 624 626 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 724 726 723 725 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 272 275 <span type="species:ncbi:10116">rat</span>
###xml 280 285 <span type="species:ncbi:9606">human</span>
###xml 726 731 <span type="species:ncbi:9606">human</span>
The polyclonal P2Y1 antiserum used in this study was raised against a P2Y1 receptor highly purified peptide (identity confirmed by mass spectroghraphy and aminoacid analysis), corresponding to a specific epitope not present in any other known protein: residues 242-258 of rat and human P2Y1 (3rd intracellular loop). The specificity of the P2Y1 receptor signal was assessed by incubating western blots either in the absence of the primary antiserum, or in the presence of the primary antiserum together with the neutralizing P2Y1 immunogenic peptide (mug protein ratio 1:1 between peptide and antiserum). Furthermore, the P2Y1 receptor polyclonal antiserum was proved to efficiently immunoprecipitate the recombinant Myc-P2Y1 human receptor transiently transfected in SH-SY5Y cells.
###end p 58
###begin title 59
Abbreviations
###end title 59
###begin p 60
###xml 301 303 <span type="species:ncbi:10116">P7</span>
DCX, doublecortin; DbetaH, dopamine beta-hydroxylase; egl, external granule layer; GFAP, glial fibrillary acidic protein; gl, granule layer; igl, internal granule layer; ml, molecular layer; NeuN, neuronal nuclei; NFL, neurofilament-L protein; pc, Purkinje cells; pl, Purkinje layer; postnatal day 7, P7; postnatal day 21, P21; TH, tyrosine hydroxylase.
###end p 60
###begin title 61
Authors' contributions
###end title 61
###begin p 62
SA carried out the immunohistological analysis, participated in the western blot examination and in the design of the study. FV purified lipid rafts from total cerebellar tissue and participated in the western blot examination. AM and GS performed electron microscopy analysis. CV conceived and coordinated the study, and participated in its design. All authors read and approved the final manuscript.
###end p 62
###begin title 63
Acknowledgements
###end title 63
###begin p 64
###xml 216 218 216 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 218 223 <span type="species:ncbi:9606">human</span>
The research presented was supported by Cofinanziamento MIUR "Purinoceptors and Neuroprotection", and grant from Ministero della Salute RF05.105V. We thank Dr. Nadia D'Ambrosi for experiments with recombinant Myc-P2Y1 human receptor transiently transfected in SH-SY5Y cells, and Dr. Patrizia Rosa and Elena Saba for the preparation of synaptosomal lipid rafts-enriched fractions.
###end p 64
###begin article-title 65
Neuronal P2 receptors of the central nervous system
###end article-title 65
###begin article-title 66
Pathophysiology and therapeutic potential of purinergic signaling
###end article-title 66
###begin article-title 67
Historical review: ATP as a neurotransmitter
###end article-title 67
###begin article-title 68
Cellular distribution and functions of P2 receptor subtypes in different systems
###end article-title 68
###begin article-title 69
P2 receptor web: complexity and fine-tuning
###end article-title 69
###begin article-title 70
Purine ionotropic (P2X) receptors
###end article-title 70
###begin article-title 71
Update of the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy
###end article-title 71
###begin article-title 72
Receptors for purines and pyrimidines
###end article-title 72
###begin article-title 73
###xml 26 31 <span type="species:ncbi:9606">human</span>
Identification of a novel human ADP receptor coupled to G(i)
###end article-title 73
###begin article-title 74
Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family
###end article-title 74
###begin article-title 75
###xml 76 81 <span type="species:ncbi:9606">human</span>
Regional and cellular distribution of the P2Y(1) purinergic receptor in the human brain: striking neuronal localisation
###end article-title 75
###begin article-title 76
Immunohistochemical localization of the P2Y(1) purinergic receptor in neurons and glial cells of the central nervous system
###end article-title 76
###begin article-title 77
Immunohistochemical localization of the P2Y1 purinergic receptor in Alzheimer's disease
###end article-title 77
###begin article-title 78
Involvement of P2 receptors in the growth and survival of neurons in the CNS
###end article-title 78
###begin article-title 79
P2Y and P2X purinoceptor mediated Ca2+ signalling in glial cell pathology in the central nervous system
###end article-title 79
###begin article-title 80
Purinergic signalling in neuron-glia interactions
###end article-title 80
###begin article-title 81
###xml 28 31 28 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12 </sub>
###xml 62 65 <span type="species:ncbi:10116">rat</span>
Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain
###end article-title 81
###begin article-title 82
Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development
###end article-title 82
###begin article-title 83
###xml 56 60 <span type="species:ncbi:10090">mice</span>
Reduced expression of P2Y1 receptors in connexin43-null mice alters calcium signaling and migration of neural progenitor cells
###end article-title 83
###begin article-title 84
Distribution of tyrosine hydroxylase-immunoreactive afferents to the cerebellum differs between species
###end article-title 84
###begin article-title 85
Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins
###end article-title 85
###begin article-title 86
###xml 35 40 <span type="species:ncbi:9606">human</span>
P2 receptor expression profiles in human vascular smooth muscle and endothelial cells
###end article-title 86
###begin article-title 87
###xml 48 51 <span type="species:ncbi:10116">rat</span>
An overview of the postnatal development of the rat cerebellum
###end article-title 87
###begin article-title 88
Neuron-glia relationship during granule cell migration in developing cerebellar cortex. A Golgi and electronmicroscopic study in Macacus Rhesus
###end article-title 88
###begin article-title 89
Doublecortin is a microtubule associated protein and is expressed widely by migrating neurons
###end article-title 89
###begin article-title 90
###xml 54 57 <span type="species:ncbi:10116">rat</span>
Postnatal development of the cerebellar cortex in the rat. III. Maturation of the components of the granular layer
###end article-title 90
###begin article-title 91
###xml 36 39 <span type="species:ncbi:10116">rat</span>
Cellular migration in the postnatal rat cerebellar cortex: confocal-infrared microscopy and the rapid Golgi method
###end article-title 91
###begin article-title 92
###xml 76 79 <span type="species:ncbi:10116">rat</span>
Distribution of dopamine-beta-hydroxylase-like immunoreactive fibers in the rat cerebellar cortex during ontogeny
###end article-title 92
###begin article-title 93
###xml 74 77 <span type="species:ncbi:10116">rat</span>
Tyrosine hydroxylase immunoreactivity in cerebellar Purkinje cells of the rat
###end article-title 93
###begin article-title 94
###xml 29 32 <span type="species:ncbi:10116">rat</span>
The monoamine innervation of rat cerebral cortex: synaptic and non-synaptic axon terminals
###end article-title 94
###begin article-title 95
Differential regulation of synaptic and extra-synaptic NMDA receptors
###end article-title 95
###begin article-title 96
Two principal modes of electrochemical communication in the brain: volume versus wiring transmission
###end article-title 96
###begin article-title 97
Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability
###end article-title 97
###begin article-title 98
###xml 56 59 <span type="species:ncbi:10116">rat</span>
Purinergic modulation of cardiovascular function in the rat locus coeruleus
###end article-title 98
###begin article-title 99
###xml 51 54 <span type="species:ncbi:10116">rat</span>
Purinergic and noradrenergic cotransmission in the rat pineal gland
###end article-title 99
###begin article-title 100
###xml 135 140 <span type="species:ncbi:10090">mouse</span>
Noradrenaline and extracellular nucleotide cotransmission involves activation of vasoconstrictive P2X(1,3)- and P2Y6-like receptors in mouse perfused kidney
###end article-title 100
###begin article-title 101
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
Noradrenaline is essential for mouse fetal development
###end article-title 101
###begin article-title 102
A central role for norepinephrine in the modulation of cerebellar learning tasks
###end article-title 102
###begin article-title 103
Cytodifferentiation of Bergmann glia and its relationship with Purkinje cells
###end article-title 103
###begin article-title 104
###xml 69 72 <span type="species:ncbi:10116">rat</span>
Non-lethal active caspase-3 expression in Bergmann glia of postnatal rat cerebellum
###end article-title 104
###begin article-title 105
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Impaired cerebellar functions in mutant mice lacking DNER
###end article-title 105
###begin article-title 106
Par6alpha signaling controls glial-guided neuronal migration
###end article-title 106
###begin article-title 107
Jagged1 ablation results in cerebellar granule cell migration defects and depletion of Bergmann glia
###end article-title 107
###begin article-title 108
ErbB4 signaling during breast and neural development: novel genetic models reveal unique ErbB4 activities
###end article-title 108
###begin article-title 109
Neuregulin and erbB receptors play a critical role in neuronal migration
###end article-title 109
###begin article-title 110
Central nervous system neuronal migration
###end article-title 110
###begin article-title 111
Astrotactin: a novel neuronal cell surface antigen that mediates neuron-astroglial interactions in cerebellar microcultures
###end article-title 111
###begin article-title 112
ATP-induced cytoplasmic calcium mobilization in Bergmann glial cells
###end article-title 112
###begin article-title 113
Binding and functions of extracellular ATP in cultured cerebellar granule neurons
###end article-title 113
###begin article-title 114
###xml 101 106 <span type="species:ncbi:9606">human</span>
Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets
###end article-title 114
###begin article-title 115
Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation
###end article-title 115
###begin article-title 116
ADP receptors of platelets and their inhibition
###end article-title 116
###begin article-title 117
###xml 124 129 <span type="species:ncbi:10090">mouse</span>
GM3-enriched microdomain involved in cell adhesion and signal transduction through carbohydrate-carbohydrate interaction in mouse melanoma B16 cells
###end article-title 117
###begin article-title 118
P2X3 receptor localizes into lipid rafts in neuronal cells
###end article-title 118
###begin article-title 119
Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation
###end article-title 119

